BOLT

Bolt Biotherapeutics, Inc. is a cutting-edge clinical-stage immuno-oncology company based in Redwood City, California, focused on transforming cancer treatment by harnessing the power of the immune system. Through its proprietary technology platform, Bolt is advancing a robust pipeline of novel drug candidates designed to enhance tumor-specific immune responses, which positions the company at the forefront of precision oncology. With a commitment to addressing significant unmet medical needs in oncology, Bolt Biotherapeutics aims to deliver impactful therapeutic solutions that can substantially improve patient outcomes in the evolving landscape of cancer immunotherapy.